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WILLIAM DOCK, MODERATOR 
Dr. William Dock (professor of 
medicine, Downstate Medical Center, 
State University of New York): One 
of the points I should like to make, is 
that smoking acts on the circulation 
only by the absorption of nicotine. It 
has nothing to do with the smoke. In 
other words, to get on the wrong side 
of the cook-out fire will not increase 
much the risk of coronary disease, 
although it might give you bronchial 
carcinoma after 50 or 100 years. Nico-
tine acts much as though the individ-
ual who smokes a cigarette or gets a 
good chew of tobacco had been given 
a good intravenous infusion of epi-
nephrine or norepinephrine. The free 
fatty acid goes up, the blood pressure 
goes up, and the stroke volume goes 
up. The stresses produced on the cir-
culation by nicotine are exactly like 
those produced by catecholamines. 
While you can change to chewing or 
switch to a pipe to get rid of obstruc-
tive emphysema, the effects of nicotine 
on the coronary vessels will be the 
same no matter how you absorb it. 
We assume the effects of smoking on 
coronary disease are what you'd ex-
pect if the patient were getting infu-
sions of epinephrine during the day, at 
regular and very frequent intervals. 
Caffeine also apparently acts in some-
what the same way. Of course, Coca-
Cola does, too. Any of these things 
can accelerate atherosclerosis some. As 
the people in Cincinnati have reported 
repeatedly, and as the nicotine sym-
posium held in New York at the Na-
tional Academy of Sciences strongly 
emphasized, chewers of tobacco have 
much worse vascular disease in the 
legs and much more coronary disease, 
age corrected, than two-pack-a-day 
cigarette smokers. Of course, they get 
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the most nicotine for their money. If 
you want nicotine, and they want nico-
tine, there is a price to pay when you 
are on the North American diet. On 
the other hand, presumably, a tobacco 
smoker in North China runs no addi-
tional risk of coronary disease, be-
cause he runs no risk to begin with. 
Dr. William Hollander (associate 
professor of medicine, Boston Uni-
versity School of Medicine): Dr. Dock, 
could I perhaps comment on the effect 
of catecholamines on the metabolism 
of the arterial wall? We have some 
observations regarding the effects of 
norephinephrine on our incubated ar-
terial tissue, including atherosclerotic 
tissue. What we have been finding is 
that, as you have indicated, catechola-
mines stimulate the lipoprotein lipase 
activity in atherosclerotic tissue. Con-
sequently, the triglyceride content falls 
off very strikingly within a period of 
four hours. You can actually measure 
a drop in the lipid content in these 
arterial walls. 
What about Buerger's disease? This 
disease can be aggravated by smoking. 
I do not know what the in vivo effects 
of norepinephrine are in Buerger's. 
And anyway, in Boston the patholo-
gists say that there is no difference be-
tween Buerger's disease and ordinary 
atherosclerotic disease of the legs. 
Sir George W . Pickering (regius 
professor of medicine, Oxford Uni-
versity): Could I disagree with that? I 
have been concerned with people with 
vascular disease of the legs ever since 
I went to work with Sir Thomas Lewis. 
These two diseases are quite different 
clinically, whatever they are like histo-
logically. Buerger's disease is a disease 
of young men which is practically un-
known in females, and it stops like that 
if you stop smoking. The influence of 
tobacco on Buerger's disease is, I 
think, 100% . 
Dr. Dock: Early Buerger's arteries 
are full of lipid only with the North 
American diet of the present time. 
When you get syphilis, or when you 
get Buerger's disease, you get athero-
sclerosis on top of it because of our 
diet. In the regions where people don't 
get highly fatty diets you can see pure 
Buerger's, and you can see pure syphi-
litic aortitis without atheroma. 
Well, we don't want any of our pa-
tients to get syphilis and we hope they 
all will stop smoking. The smoking 
influence is so clear-cut in statistical 
studies that it is a tragedy that it is 
easier for a patient to have blood 
drawn every week to see how his pro-
thrombin is doing, and take Coumadin 
pills, than it is for him to stop buying 
tobacco. Tobacco is an extremely ad-
dicting drug, probably as addicting as 
morphine. And the physiological dam-
age done by tobacco or nicotine is 
certainly much worse than that done 
by morphine. If you don't smoke 
opium, you don't get obstructive em-
physema from it. If you take morphine 
in little pills, it makes you feel good 
just the way smoking does, but it does 
not produce the catecholamine effect, 
and there is no evidence that it pro-
duces arteriosclerosis or even aggra-
vates it. So, we are hoping to get the 
Narcotic Act repealed! Everybody on 
the panel but me and Dr. Stamler, I 
think, are two-pack-a-day or nine-
pipe-a-day smokers. You see how hard 
it is to stop the addiction. Dr. Picker-
ing and I knew three full professors of 
medicine in leading American univer-
sities who died of obstructive emphy-
sema. Not one of these men could cut 
down his smoking though he knew he 
was headed for the boneyard. One of 
them used to sneak into his garret and 
smoke so his wife could not catch him, 
and this was after he had been in the 
hospital and in a helium tent. So, we 
have agreed on the panel that you can-
not give up smoking, and most of us 
agree, I think, that patients cannot be 
persuaded to stay on diets. Dr. Stam-
ler, can they be persuaded? 
Dr. Jeremiah Stamler (director of 
the heart disease control program, 
City of Chicago Board of Health): The 
question is not whether people can be 
persuaded to stay on a diet. I think the 
question is whether a population can 
change its eating habits sufficiently to 
alter the pattern of a disease. If what 
we are really talking about is meaning-
ful and important, it has a whole lot of 
sociological consequences which come 
into play beginning with the earliest 
period of habit formation, in the time 
of weaning. I was talking with Dr. 
William Harlan about what happens to 
young men in America. They are very 
active in athletics, they develop the 
training table or the basic training pat-
tern of eating. Then they stop physical 
activity when they cease to be active in 
athletics or leave the armed forces, but 
they keep on eating the same way. Or, 
even worse, they fall into the hands of 
a wonderful, lovely little girl who 
wants to show that she learned the 
right things from Mamma about cook-
ing. 
Dr. Dock: Now, Dr. Pickering, I 
think we should give you a chance to 
get back into the argument. In the first 
place, does your group feel that diet 
has any importance whatever in the 
pathogenesis of vascular disease? 
Prof. Pickering: As August Krogh 
once remarked, "Physiological phe-
nomena are so complicated that, if you 
argue from more than one step to 
another without the control of experi-
ment, you are almost certain to go 
wrong." Before I would be prepared 
to encourage a mass change of diet, I 
would like to have a pilot study to see 
that this mass change was doing a cer-
tain amount of good. If I remember 
rightly, there is a certain well-known 
professor of medicine who put himself 
on a very rigid low-fat, no cholesterol 
diet, and has since had a cholesterol 
stone removed from his gall bladder. 
Dr. Dock: And you conclude that it 
formed after he went on the diet? 
Prof. Pickering: Well, he may have 
had it before, that is perfectly true. 
Dr. Dock: I think that Dr. Pickering 
has brought up a very important point. 
A man with asymptomatic gall stones 
who goes on a diet with vegetable oil 
is very likely to have his stones de-
crease in size to where they can slip 
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into the cystic or common duct. Then 
he will have his first attack of colic 
one, two, or three years after he has 
cut his cholesterol intake, because the 
stones will get smaller and give symp-
toms. I have had three such patients. 
One of them had his gall stones taken 
out at Peter Bent Brigham Hospital 
after his fifth attack of colic. His first 
attack came on about three years after 
he changed his diet. Fortunately he 
had had his gall bladder visualized 
eight years before, and beautiful, big 
cholesterol stones had been seen, far 
too big to get into his duct. 
I think that if you try to starve too 
fast, you may run your serum tri-
glycerides up quite high by starvation. 
People have their first bout of myo-
cardial infarction just after they have 
gone on a marked weight reduction 
program. This has been noted over and 
over again. There is a great craze now 
in parts of the United States for star-
vation as the way to start a weight re-
duction program. It can be predicted 
that this should up the incidence of 
coronary disease in the first three 
months after you go on that sort of 
program. Whether it will, I don't 
know. 
I think that physicians who feel, as 
Dr. Pickering and his group do, that 
the role of diet in vascular disease is 
not yet established, should say as much 
to their patients. This seems to me to 
be perfectly sound, rational manage-
ment. 
On the other hand, Pickering is a 
doctor who thinks perhaps Harvey was 
right in saying that if animal experi-
ment indicates that the blood circu-
lates, then it may circulate in man. If 
you take animal experiment as being 
relevant to human physiology and pa-
thology, and you know that dietary 
manipulation will produce vascular 
disease in chickens, rats, guinea pigs, 
rabbits, dogs, hamsters, monkeys, and 
pigs, it does become a little awkward 
to say, "Well, we don't believe that 
animal experiment is relevant to hu-
man experience in this particular 
field." It is perfectly sound doctrine to 
say this, as it was for Dr. Sydenham to 
say, "Just because Harvey thought that 
blood circulated in a snake or a deer 
is no reason to think that blood circu-
lates in man." To me, this is perfectly 
sound, rational argument. Sydenham 
was the greatest internist of his gen-
eration. You can be a great man in 
your generation, and it may turn out 
that you were right. Or, it may turn 
out that you did not take as seriously 
as you should have the data that were 
available. 
Prof. Pickering: Yes, there is a little 
difference, though. You will recall that 
Krogh said, "If you argue from one set 
of data to another without the control 
of experiment you are likely to go 
wrong." And I believe that there is a 
difference between the rabbit and the 
human being. The diet that rabbits eat 
in experiments is very different from 
the diets that they ordinarily eat. And 
the lesion which is produced in rabbits 
is not quite the same as the lesion 
which produces myocardial infarction 
in men. And so, I think your reasoning 
will not hold up at every point, and 
even if it did, man is a different species 
from rabbit. I would like to see the 
effect of diet demonstrated in man be-
fore I am prepared to believe it is ef-
fective in controlling vascular disease. 
Dr. Dock: Well, this experiment is 
under way in the United States at enor-
mous expense at the present time. 
Dr. Stamler: Could I just say a word 
about this? I didn't get to hear Sir 
George, but I have read some of his 
writings, and I had the good fortune 
to hear the tape of his lecture earlier 
in this symposium. I'd like to dismiss 
one or two of the arguments which I 
don't think are entirely valid, or, if not 
dismiss them, at least put them on the 
table for rediscussion. The first is the 
question of the rabbit as an atypical 
species. The second is the matter of 
drowning the animals in very high cho-
lesterol, high fat diets. Both of these 
were problems in 1948. I do not think 
either is much of a problem now for 
the following reasons: 1) The disease 
has, in fact, been reproduced, with a 
lesion remarkably similar to the hu-
man lesions, in a wide range of species, 
as Dr. Dock said. So the problem that 
did confront workers in the 1930's, 
that of the ability to reproduce the dis-
ease only in the rabbit or guinea pig, 
is no longer entirely true. In fact, quite 
the opposite is true. We have the dog, 
rat, chicken, rabbit, and a variety of 
monkeys. The monkey experiments 
have been done using diets similar to 
the human diet, in fact, feeding human 
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foods in periods that correspond to a 
life span equivalent to human beings. 
These produced moderate elevations 
of the serum cholesterol level in the 
200's and 300's, peripheral gangrene, 
myocardial infarction, and cerebral in-
farction. 
On the question of experiment in 
man, I would like to add a word to 
that. As practicing doctors, I think 
that the profession has a very difficult 
problem. Let's face it, these studies in 
the population may not come off. If 
they do come off, they will take a dec-
ade at least to get an answer. And 
what does one do in the interim, wait 
for the results of the experiment, and 
say, "Well, we're not sure." That's OK, 
but every physician who makes that 
decision has to accept the corollary of 
it, and even has to tell his patient of 
the corollary. "If you are a high risk, 
middle-aged American man, I have 
very little to offer you while I'm wait-
ing for the purity of a scientific an-
swer." Because, really, we do not have 
much to offer aside from our approach 
to these risk factors, of which diet, 
blood cholesterol, and weight are three 
key ones. If we are prepared to accept 
that corollary, and transmit it to our 
patients, then I say we can wait for 
the big experiment, if it ever gets done. 
If not, I think we should intervene in 
a safe way. 
Prof. Pickering: Well, that is what I 
think I said. If the doctor, himself, 
does not believe in this, he should tell 
his patients he does not believe in it. 
If they want to go on the diet, he is 
glad to direct them. If he does believe 
in it, he has got to practice what is 
known as the Golden Rule and say, "If 
I had your trouble, this is what I would 
do . . .. " I think this is the best any of 
us can do. The same thing applies to 
the use of anticoagulants. If the pa-
tient says, "Well, would you take this 
yourself?" I have to tell him that I 
hate to have my arms stuck every 
week, and for a difference in mortality 
of 4% as against 5% a year, roughly, 
I don't believe I would take all of this 
trouble. 
Dr. Stamler and I have rather dif-
ferent views about atherosclerosis, I 
think. He would include a lot of le-
sions that I suspect are not the same. 
Dr. Stam/er: I include only lesions 
with porridge in them-no lipid, no 
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atherosclerosis, as far as I am con-
cerned. Patients who have been starved 
have fibrous plaques and calcium, but 
no demonstrable lipid when they die. 
It is true in man that the lipid can dis-
appear so you see only the scar of the 
disease. If I had to limit the diagnosis 
of syphilitic aortitis to people in whom 
I could demonstrate treponemes, I 
would be out of luck, because peni-
cillin has killed the treponemes in all 
of my patients. Just as I diagnose 
former syphilitic aortitis from sections, 
I now diagnose former atherosclerosis 
at autopsy in patients who, as a result 
of leukemia, say, have lost a great deal 
of weight and been markedly under-
nourished through periods of about 
two years before they died. So you can 
lose the lipid from plaques, I'm sure. 
Furthermore, I believe that lipid is 
present in the lesions of adolescence in 
larger quantities than it is in the lesions 
of men of 40, and is present in larger 
quantities in men who die at 40 than 
it is in men who die at 70. These are 
my own views. This is almost a ques-
tion of religious experience. Dr. Pick-
ering belongs to one church, and has 
had one religious background in this 
field . I belong to a different church, 
having had different clergymen work-
ing on me in my youth. So, I don't ex-
pect to convince Professor Pickering 
that the lesions I showed in small ves-
sels are related to the lesions that the 
same patients had in their coronary ar-
teries, although both of those patients 
from whom I showed you sections 
were hypertensives with hypercholes-
terolemia who died of myocardial in-
farction. They had lesions in small ar-
teries. Dr. Pickering thinks these are 
unrelated to the lesions in the coro-
naries. I cannot see why they might 
not be the same lesions. 
Prof. Pickering: Well, I think they 
are different. Partially because they 
look different, and partially because, in 
the small arteries, kidney, and in the 
retinal arterioles, lesions are much 
more closely correlated with the 
height of the arterial pressure than is 
the disease I was talking about which 
produces big nodules in arteries like 
the carotid, and ultimately leads to 
thrombosis of them. 
I will not agree with Dr. Dock that, 
because you can see lipid in them both, 
they represent the same disease. He 
says we belong to different churches. I 
think he does belong to a church. I am 
just a plain agnostic. 
Dr. William R. Harlan, Jr. (direc-
tor of clinical research center, Medi-
cal College of Virginia): It is much 
easier to make long studies of large 
series of cases with a drug than it is 
with a diet, and I think this may turn 
out in the end to be a more profitable 
way of shedding light on what the 
plasma lipid has to do with arterio-
sclerosis in man. It will not settle 
whether plasma lipid acts by acceler-
ating coagulation, but at least it would 
cast some light on whether changing 
the lipid levels in the plasma would 
improve the prognosis. 
We ought to ask Dr. Stamler about 
estrogens and the drug androsterone, 
which we produce in our bodies-a 
very weak androgen but it tends to 
lower blood cholesterol. These two 
agents can be given to lower plasma 
lipid, at least plasma cholesterol levels, 
in male patients. Are you still carrying 
on estrogen studies? 
Dr. Stam/er: In brief, there are three 
reports of a controlled nature on the 
estrogens in post-myocardial infarc-
tion in man. One of them is a British 
study by Oliver and Boyd that deals 
with 100 patjents up to age 65. An-
other is an American study that deals 
with men of all ages on lower doses 
of mixed conjugated equine estrogen. 
Oliver and Boyd used ethanyl estradiol. 
The third study is by our group in Chi-
cago, using mixed conjugated equine 
estrogens in men under 50. In the 100 
patients whom they studied, Oliver and 
Boyd got completely negative results, 
although serum cholesterol levels were 
lower. The Los Angeles study with 
lower doses of mixed conjugated 
equine estrogen is still in progress, but 
there are positive results, particularly 
in the patients under 50. I think none 
of these studies to date permits a clean-
cut decision on the efficacy of estro-
gens. I might note that there is a pe-
culiar aspect to the estrogen work; 
while ethanyl estradiol consistently 
lowers total blood cholesterol level, 
mixed conjugated equine estrogens do 
not. They shift the lipoprotein pattern, 
but they do not consistently lower the 
total cholesterol level. They raise the 
a- and may lower the /3- propor-
tionately, so that total cholesterol 
changes very little. They do, unques-
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tionably, convert the a- from a male 
level of about 50 or so to a female 
level of 250, 300, 350, or greater. 
Whether this is efficacious is, of course, 
moot. 
Dr. Dock: One of the questions is 
whether a reduction in blood pressure 
will help us have a lower incidence of 
cardiovascular disease. I think you be-
lieve it will. 
Prof. Pickering: No, I don't believe 
it will. I think the evidence suggesting 
this is bad. 
Dr. Dock: You said that in severe 
hypertensives, lowering blood pressure 
changes the whole course of the dis-
ease. If this is true, how can it help 
but lower the death rate? 
Prof. Pickering: Oh, I thought you 
were talking about arteriosclerosis. 
Dr. Dock: No, no. In any sort of 
vascular disease, will lowering the 
blood pressure improve the prognosis? 
Prof. Pickering: Well, it depends on 
how high the blood pressure is. If the 
blood pressure is very high, or if you 
get a patient in the malignant phase 
before the kidneys are really very se-
verely involved, then I think the evi-
dence is quite clear that you can pro-
long the expectation of life. 
Dr. Dock: But in a patient with a 
lower level of blood pressure and with 
a myocardial infarct, is it worthwhile 
to try to lower the blood pressure? 
Prof. Pickering: No, I would not say 
that. But I think that I have distin-
guished what I would regard as estab-
lished, and what I would regard as a 
sufficient degree of probability, so that 
I would use it in the treatment of my 
patients. I do not regard it as estab-
lished that diet will reduce the preva-
lence of myocardial infarction, but in-
stead, I do advise my patients: 1) to 
try to regain their youthful figures, 2) 
to substitute corn oil for their ordinary 
cooking fat, 3) to take as much exer-
cise as they conveniently can, 4) if 
their arterial pressure is high, I reduce 
it, and 5) if they are under 55 and 
male, I put them on anticoagulants, 
but I do not ever go very high with 
them, because I am afraid of them. I 
do not use anticoagulants in patients 
with peptic ulcer, gross hypertension, 
or liver disease. 
Dr. Dock: Well, I think with this 
useful advice, perhaps we had better 
bring the meeting to a close. 
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